
Kellyann Niotis
Articles
-
Sep 28, 2024 |
peterattiamd.com | Taylor D. Yeater |Kathryn Birkenbach |Kellyann Niotis |Peter Attia
As we age, forgetfulness and dementia become significant health concerns, with memory and learning being especially vulnerable. The hippocampus (the brain region largely responsible for the consolidation of these memories) has been shown to decrease in volume with age.1 Perhaps preventing or reversing hippocampal atrophy (shrinkage) and the associated decline in learning and memory could prevent the onset of dementia.
-
Nov 11, 2023 |
peterattiamd.com | Kathryn Birkenbach |Tom Dayspring |Kellyann Niotis |Peter Attia
As I’ve discussed in a recent “Ask Me Anything” episode on metabolic health, obesity (and the metabolic dysfunction that often accompanies it) is a risk factor for many of mankind’s deadliest diseases. But the relationship isn’t always straightforward – such as in the case of cognitive decline. While obesity has been reported by some to increase risk of dementia, other studies have reported just the opposite – that obesity is protective against dementia.
-
Sep 12, 2023 |
sheknows.com | Jocelyn Solis-Moreira |Kellyann Niotis
By 2050, neurologists predict the number of people living with Alzheimer’s will jump to 150 million worldwide — and women are likely to make up a good portion of this caseload. Alzheimer’s affects almost twice as many women as men. Some experts have suggested that it’s because women, on average, live longer than men do. But that’s not the whole picture. Other factors may include lifestyle factors such as stress, hormone changes that occur during menopause, as well as immune system function.
-
Aug 4, 2023 |
sheknows.com | Jocelyn Solis-Moreira |Kellyann Niotis
If you purchase an independently reviewed product or service through a link on our website, SheKnows may receive an affiliate commission. It’s a big year in the world of Alzheimer’s research. In early July, the FDA approved the Alzheimer’s drug Leqembi, which is the first drug to show clinical evidence of slowing down cognitive decline.
-
Mar 30, 2023 |
yahoo.com | Kellyann Niotis
Read full articleDr. Kellyann Niotis is a preventive neurologist specializing in risk reduction strategies for neurodegenerative disorders including Alzheimer’s disease, Lewy body dementia, and Parkinson’s disease. She leads the preventive neurology program at Early Medical. This is a transcript of Master Mind: Optimizing Brain Health from the SHE Media Co-Lab’s Future of Health event at SXSW. […]More than 45,000 shoppers are fans of this formula: 'Seeing results.'"I love the idea of ...
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →